Istari Oncology Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Istari Oncology's estimated annual revenue is currently $2.3M per year.(i)
  • Istari Oncology's estimated revenue per employee is $155,000

Employee Data

  • Istari Oncology has 15 Employees.(i)
  • Istari Oncology grew their employee count by -25% last year.

Istari Oncology's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
Chief Staff and Director, Program ManagementReveal Email/Phone
3
Head BiostatisticsReveal Email/Phone
4
VP, FinanceReveal Email/Phone
5
VP, Human Resources & AdministrationReveal Email/Phone
6
Senior Director, Translational Medicine, ClinicalReveal Email/Phone
7
Executive Director, Program ManagementReveal Email/Phone
8
Director Quality AssuranceReveal Email/Phone
9
Senior Director, Manufacturing OperationsReveal Email/Phone
10
VirologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Istari Oncology?

Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The company was founded by Darell Bigner, MD, and Matthias Gromeier, MD, of Duke University Medical Center in 2016. Both are leaders in their respective research fields of virology, immunology, monoclonal development and clinical medicine, particularly in the treatment of brain tumors.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

-25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M15N/AN/A
#2
$1.8M15-37%N/A
#3
$1.3M15N/AN/A
#4
$7.5M17N/AN/A
#5
$1.5M17143%N/A